首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >The In-depth quantitative proteomic and phosphoproteomic study of clinical sera derived from the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) cohort: The quest for potential prediction biomarkers of pharmacologic effic acy
【24h】

The In-depth quantitative proteomic and phosphoproteomic study of clinical sera derived from the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) cohort: The quest for potential prediction biomarkers of pharmacologic effic acy

机译:临床血清的深入定量蛋白质组学和磷蛋白蛋白酶研究源自散发性患者与遗传性乳腺癌(POSH)癌症的前瞻性研究(POSH)队列:寻求药理学效应射频的潜在预测生物标志物

获取原文

摘要

This work adds new evidence to the field of drug efficacy and prognosticators in early onset breast cancer and opens new venues for novel biomarkers and pathway discovery. Such critical biological pathways revealed by this effort will be exploited for potential new pharmaceutical agents to alter the overall disease outcome.
机译:这项工作为早期发作乳腺癌药物疗效和预后剂的领域增加了新的证据,并开启了新的生物标志物和途径发现的新场所。通过这种努力揭示了这种关键的生物途径,将利用潜在的新药剂来改变整体疾病结果。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号